Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance
H. Onafuye, S. Pieper, D. Mulac, J. Cinatl, M. N. Wass, K. Langer, M. Michaelis
This study shows that doxorubicin-loaded human serum albumin nanoparticles enhance anti-cancer activity in drug-resistant neuroblastoma cells by bypassing ABCB1-mediated efflux.
bioRxiv · May 31, 2019Pharmacology & Toxicology